Dezhan Healthcare Co Stock Fundamentals

000813 Stock   3.17  0.08  2.59%   
Dezhan HealthCare Co fundamentals help investors to digest information that contributes to Dezhan HealthCare's financial success or failures. It also enables traders to predict the movement of Dezhan Stock. The fundamental analysis module provides a way to measure Dezhan HealthCare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dezhan HealthCare stock.
At present, Dezhan HealthCare's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 831.1 M, whereas Selling General Administrative is forecasted to decline to about 130.3 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Dezhan HealthCare Co Company Current Valuation Analysis

Dezhan HealthCare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Dezhan HealthCare Current Valuation

    
  4.08 B  
Most of Dezhan HealthCare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dezhan HealthCare Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Dezhan HealthCare Co has a Current Valuation of 4.08 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.

Dezhan HealthCare Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Dezhan HealthCare's current stock value. Our valuation model uses many indicators to compare Dezhan HealthCare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dezhan HealthCare competition to find correlations between indicators driving Dezhan HealthCare's intrinsic value. More Info.
Dezhan HealthCare Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Dezhan HealthCare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Dezhan HealthCare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Dezhan Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dezhan HealthCare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dezhan HealthCare could also be used in its relative valuation, which is a method of valuing Dezhan HealthCare by comparing valuation metrics of similar companies.
Dezhan HealthCare is currently under evaluation in current valuation category among its peers.

Dezhan Fundamentals

About Dezhan HealthCare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dezhan HealthCare Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dezhan HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dezhan HealthCare Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue498.1 M831.1 M
Cost Of Revenue205.5 M210.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Dezhan Stock

Dezhan HealthCare financial ratios help investors to determine whether Dezhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dezhan with respect to the benefits of owning Dezhan HealthCare security.